Literature DB >> 35036312

The role of Platelet Rich Plasma and other orthobiologics in bone healing and fracture management: A systematic review.

M S Jamal1, E T Hurley2, H Asad1, A Asad1, T Taneja1,3.   

Abstract

BACKGROUND: Treatment of large bone defects and fracture healing complications (delayed and non-union) presents a substantial challenge for orthopaedic surgeons. Given that bone healing requires mechanical stability as well as a favourable biological microenvironment, orthobiologics such as Platelet-Rich Plasma (PRP) may have a significant clinical role to play. AIMS: To perform a systematic review of the available literature to assess the clinical effect of PRP, with or without other orthobiologics, on bone healing.
METHOD: Two independent reviewers performed the literature search based on the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines. Clinical studies of any evidence, assessing effect of PRP with or without other orthobiologics on bone healing, were included. A qualitative analysis was carried out on the clinical and radiological outcomes reported. RESULT: 27 articles with 1631 patients (mean age = 43.56, 57.1% male, mean follow-up = 17.27 months) were included in the qualitative. Of the 27 studies, 13 dealt with fracture complications (delayed or non-unions), 7 with acute fracture healing, 4 with tibial osteotomies and lengthening procedures and 3 with lumbar spine pathology. 18/27 studies showed a clinical benefit of PRP, 8/27 showed no significant effect, and 1/27 showed a worse outcome with PRP.
CONCLUSION: Our review suggests PRP may play a clinical role in bone healing but further randomised controlled trials (RCTs) using standardised outcomes should be performed to establish its efficacy.
© 2021.

Entities:  

Keywords:  Delayed union; Fracture healing; Non-union; Orthobiologic; PRP; Platelet-rich plasma

Year:  2022        PMID: 35036312      PMCID: PMC8749440          DOI: 10.1016/j.jcot.2021.101759

Source DB:  PubMed          Journal:  J Clin Orthop Trauma        ISSN: 0976-5662


  65 in total

1.  Lumbar Intradiskal Platelet-Rich Plasma (PRP) Injections: A Prospective, Double-Blind, Randomized Controlled Study.

Authors:  Yetsa A Tuakli-Wosornu; Alon Terry; Kwadwo Boachie-Adjei; Julian R Harrison; Caitlin K Gribbin; Elizabeth E LaSalle; Joseph T Nguyen; Jennifer L Solomon; Gregory E Lutz
Journal:  PM R       Date:  2015-08-24       Impact factor: 2.298

2.  Using the growth factors-enriched platelet glue in spinal fusion and its efficiency.

Authors:  Chun-Hao Tsai; Horng-Chaung Hsu; Yen-Jen Chen; Mou-Jyn Lin; Hsien-Te Chen
Journal:  J Spinal Disord Tech       Date:  2009-06

3.  Results of the use of platelet rich plasma in the treatment of delayed union of long bones.

Authors:  Justyna Gołos; Tomasz Waliński; Piotr Piekarczyk; Krzysztof Kwiatkowski
Journal:  Ortop Traumatol Rehabil       Date:  2014 Jul-Aug

Review 4.  Platelet-rich plasma for the treatment of bone defects: from pre-clinical rational to evidence in the clinical practice. A systematic review.

Authors:  Alice Roffi; Berardo Di Matteo; Gopal Shankar Krishnakumar; Elizaveta Kon; Giuseppe Filardo
Journal:  Int Orthop       Date:  2016-11-26       Impact factor: 3.075

Review 5.  Platelet rich therapies for long bone healing in adults.

Authors:  Xavier L Griffin; David Wallace; Nick Parsons; Matthew L Costa
Journal:  Cochrane Database Syst Rev       Date:  2012-07-11

6.  Is platelet-rich plasma injection an effective choice in cases of non-union?

Authors:  F Say; E Türkeli; M Bülbül
Journal:  Acta Chir Orthop Traumatol Cech       Date:  2014       Impact factor: 0.531

7.  Efficacy of autologous growth factors in lumbar intertransverse fusions.

Authors:  Bradley K Weiner; Matthew Walker
Journal:  Spine (Phila Pa 1976)       Date:  2003-09-01       Impact factor: 3.468

Review 8.  Current Clinical Recommendations for Use of Platelet-Rich Plasma.

Authors:  Adrian D K Le; Lawrence Enweze; Malcolm R DeBaun; Jason L Dragoo
Journal:  Curr Rev Musculoskelet Med       Date:  2018-12

9.  Platelet-rich therapy in the treatment of patients with hip fractures: a single centre, parallel group, participant-blinded, randomised controlled trial.

Authors:  Xavier L Griffin; Juul Achten; Nick Parsons; Matt L Costa
Journal:  BMJ Open       Date:  2013-06-25       Impact factor: 2.692

10.  To evaluate the role of platelet-rich plasma in healing of acute diaphyseal fractures of the femur.

Authors:  Roop Singh; Rajesh Rohilla; Jeetesh Gawande; Paramjit Kumar Sehgal
Journal:  Chin J Traumatol       Date:  2017-01-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.